Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
- PMID: 21388550
- PMCID: PMC3061907
- DOI: 10.1186/1471-2334-11-60
Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
Abstract
Background: Poor outcomes of invasive candidiasis (IC) are associated with the difficulty in establishing the microbiological diagnosis at an early stage. New scores and laboratory tests have been developed in order to make an early therapeutic intervention in an attempt to reduce the high mortality associated with invasive fungal infections. Candida albicans IFA IgG has been recently commercialized for germ tube antibody detection (CAGTA). This test provides a rapid and simple diagnosis of IC (84.4% sensitivity and 94.7% specificity). The aim of this study is to identify the patients who could be benefited by the use of CAGTA test in critical care setting.
Methods: A prospective, cohort, observational multicentre study was carried out in six medical/surgical Intensive care units (ICU) of tertiary-care Spanish hospitals. Candida albicans Germ Tube Antibody test was performed twice a week if predetermined risk factors were present, and serologically demonstrated candidiasis was considered if the testing serum dilution was ≥ 1:160 in at least one sample and no other microbiological evidence of invasive candidiasis was found.
Results: Fifty-three critically ill non-neutropenic patients (37.7% post surgery) were included. Twenty-two patients (41.5%) had CAGTA-positive results, none of them with positive blood culture for Candida. Neither corrected colonization index nor antifungal treatment had influence on CAGTA results. This finding could corroborate that the CAGTA may be an important biomarker to distinguish between colonization and infection in these patients. The presence of acute renal failure at the beginning of the study was more frequent in CAGTA-negative patients. Previous surgery was statistically more frequent in CAGTA-positive patients.
Conclusions: This study identified previous surgery as the principal clinical factor associated with CAGTA-positive results and emphasises the utility of this promising technique, which was not influenced by high Candida colonization or antifungal treatment. Our results suggest that detection of CAGTA may be important for the diagnosis of invasive candidiasis in surgical patients admitted in ICU.
Similar articles
-
Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.Mycopathologia. 2017 Aug;182(7-8):645-652. doi: 10.1007/s11046-017-0125-9. Epub 2017 Apr 4. Mycopathologia. 2017. PMID: 28378240
-
Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients.J Microbiol Immunol Infect. 2020 Oct;53(5):778-784. doi: 10.1016/j.jmii.2019.02.001. Epub 2019 Mar 11. J Microbiol Immunol Infect. 2020. PMID: 30902614
-
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.Intensive Care Med. 2015 Aug;41(8):1424-32. doi: 10.1007/s00134-015-3922-y. Epub 2015 Jul 2. Intensive Care Med. 2015. PMID: 26134359
-
Diagnostic accuracy of Candida albicans germ tube antibody for invasive candidiasis: systematic review and meta-analysis.Diagn Microbiol Infect Dis. 2019 Apr;93(4):339-345. doi: 10.1016/j.diagmicrobio.2018.10.017. Epub 2018 Nov 6. Diagn Microbiol Infect Dis. 2019. PMID: 30552034
-
[Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].Rev Iberoam Micol. 2013 Jul-Sep;30(3 Suppl 1):135-49. doi: 10.1016/j.riam.2013.05.005. Epub 2013 Jun 11. Rev Iberoam Micol. 2013. PMID: 23764554 Spanish.
Cited by
-
Anti-Candida Antibodies of Patients with Invasive Candidiasis Inhibit Growth, Alter Cell Wall Structure, and Kill Candida albicans In Vitro.Mycopathologia. 2024 Feb 7;189(1):16. doi: 10.1007/s11046-023-00819-w. Mycopathologia. 2024. PMID: 38324097 Free PMC article.
-
Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach.Folia Microbiol (Praha). 2012 Sep;57(5):421-30. doi: 10.1007/s12223-012-0152-3. Epub 2012 May 8. Folia Microbiol (Praha). 2012. PMID: 22566119 Review.
-
Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.Mycopathologia. 2017 Aug;182(7-8):645-652. doi: 10.1007/s11046-017-0125-9. Epub 2017 Apr 4. Mycopathologia. 2017. PMID: 28378240
-
Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later.Intensive Care Med. 2014 Oct;40(10):1429-48. doi: 10.1007/s00134-014-3355-z. Epub 2014 Jun 17. Intensive Care Med. 2014. PMID: 24934813 Free PMC article. Review.
-
Influence of cancer treatment on the Candida albicans isolated from the oral cavities of cancer patients.Support Care Cancer. 2016 Jun;24(6):2429-36. doi: 10.1007/s00520-015-3035-8. Epub 2015 Dec 5. Support Care Cancer. 2016. PMID: 26638003
References
-
- Zaragoza R, Pemán J. Diagnostic and therapeutic approach to fungal infections in critical care settings: different options but the same strategy. J Invasive Fungal Infect. 2007;1:50–58.
-
- Kullberg BJ, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Rex JH. et al.Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet. 2005;366:1435–1442. doi: 10.1016/S0140-6736(05)67490-9. - DOI - PubMed
-
- Pachl J, Svoboda P, Jacobs F, Vandewoude K, van der HB, Spronk P. et al.A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis. 2006;42:1404–1413. doi: 10.1086/503428. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical